Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 2 The association between clinical characteristic and pretreatment/post-treatment NLR values

From: Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study

 

N (%)

NLR 1

NLR 2

p

Type

 

AIDP

18 (51.4%)

3.47 ± 1.04

1.98 ± 0.45

< 0.001*

AMAN

7 (20%)

4.04 ± 1.85

2.17 ± 0.61

< 0.02*

AMSAN

10 (25.7%)

4.94 ± 1.08

2.51 ± 1.06

< 0.001*

  

P < 0.02*

P < 0.18

 

History of infection

No

15(42.9%)

3.67 ± 1.22

2.21 ± 0.63

< 0.001*

Yes

20 (57.1%)

4.33 ± 1.45

2.34 ± 0.92

0.001*

  

P 0.12

P 0.80

 
  1. AIDP acute inflammatory demyelinating polyneuropathy, AMSAN acute motor-sensory axonal neuropathy, AMAN acute motor axonal neuropathy, NLR1: neutrophil–lymphocyte ratio before plasmapheresis, NLR2 neutrophil–lymphocyte ratio after plasmapheresis
  2. *Statistically significant at p < 0.05
Back to article page